$ARQ

Arq, Inc. (ARQ): Results of Operations and Financial Condition

Arq, Inc. (ARQ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Arq Reports Second Quarter 2026 Results Generated revenue of approximately $30 million, up 5% Reported Adjusted EBITDA (1) of approximately $5.8 million, up 59% on prior year period 9 th consecutive quarter of positive Adjusted EBITDA, driven by foundational PAC busi

Original reporting
Published Aug 10, 2026, 8:53 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 8:55 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$ARQ
Bullish
medium confidence
Mentioned
$ARQ
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ARQBullishMed
01

Why it matters

Traders can update valuation and positioning based on the quarter’s profitability improvement, gross margin expansion, and the reaffirmed full-year revenue and Adjusted EBITDA range.

02

Market read

Fresh quarterly financials plus explicit guidance reaffirmation typically drive near-term repricing for small-cap industrials, especially when profitability metrics improve materially.

03

What to watch

Large restricted cash balance and the reliance on non-GAAP Adjusted EBITDA could mask underlying cash flow volatility; severance and recruiting costs also rose year over year.

Relevance 7/10Novelty 7/10Timing: after-hours filing on Aug 10, 2026 (Q2 results and guidance reaffirmation)

Background

This SEC 8-K includes Arq’s Q2 2026 results (Item 2.02) and an attached earnings release (Exhibit 99.1).

Company-level read

Ticker impact

$ARQBullishMedium confidence
Context

Arq reported Q2 2026 revenue of $29.9M, Adjusted EBITDA of $5.8M, and reaffirmed 2026 guidance of $120-125M revenue and $17-20M Adjusted EBITDA.

Expected impact

Likely positive bias for ARQ shares on guidance confidence, with follow-through dependent on continued PAC margin and PFAS/PAC commercialization progress.

Evidence & confidence

The filing provides fresh quarterly datapoints (revenue, gross margin, net loss, Adjusted EBITDA) plus explicit reaffirmed full-year targets, which are actionable for traders repricing the earnings power outlook.

Market effects

Reinforces demand and margin durability for activated carbon/PAC used in water purification and PFAS mitigation, a niche environmental services/materials theme.

No clear regional spillover beyond US-listed small-cap industrial/environmental materials sentiment.

Limited global relevance; story is company-specific with PFAS-related commercialization optionality.

Counterpoint

Despite strong Adjusted EBITDA, the company still reported a net loss and carries execution risk around GAC expansion, PFAS for PAC scaling, and monetizing the Corbin Facility.

Key entities

  • Arq, Inc.

    Producer of activated carbon and related environmentally efficient carbon products; reported Q2 2026 results and reaffirmed 2026 guidance.

  • Bob Rasmus

    CEO quoted on PAC earnings power, turnaround completion, and PFAS-related PAC strategy progress.

  • Shimon Steinmetz

    Appointed CFO in May 2026, started July 2026.

Related articles

$ARQMed

Arq (ARQ) Q2 2026 Earnings Call Transcript

Arq (ARQ) held its Q2 2026 earnings call, citing revenue of about $30 million, gross margin around 38.5% (up ~520 bps), and adjusted EBITDA of about $5.8 million. The company discussed PAC for PFAS for near-term compliance ahead of EPA PFAS rules, and reiterated full-year CapEx of $8 million to $10 million.

$LLYMed

Eli Lilly’s $100B incretin opportunity: Is more upside coming?

J.P. Morgan raised its 2027 revenue estimate for Eli Lilly to $105.67B and EPS forecast to $50.99, maintaining an Overweight rating and $1,400 price target. The bank expects significant growth from Lilly's incretin portfolio, including Zepbound and Mounjaro, with combined sales forecasted to exceed $100B by 2030. Key risks include pricing pressure and competition.

$OKTAHighAI 9/10

Okta Jumps 20% as AI-Driven Security Fears Fuel a Beat-and-Raise Quarter

Okta, Inc. (OKTA) shares rose 29% after beating fiscal Q2 estimates, with revenue at $805M vs. $795M expected and EPS at $1.05 vs. $97 expected. Net income increased to $116M, and backlog grew 17% to $4.86B. The company launched 'Okta for AI Agents' and raised full-year revenue guidance to $3.22B-$3.23B. CEO Todd McKinnon highlighted AI's role in transforming technology.

$SNOWHighAI 8/10

Prediction: Snowflake's Product Revenue Passes $8 Billion in Fiscal 2028

Snowflake (SNOW) reported fiscal Q2 2027 with accelerating growth, driven by AI products. Shares rose over 20%. The company raised its product revenue guidance to $6.07B (36% YoY growth) and adjusted operating margin outlook to 14.5%. Management predicts $8B in product revenue by fiscal 2028, citing strong customer retention and AI adoption.

$CHPTMed

Overlooked EV stock surges despite buyers abandoning zero-emission cars

ChargePoint (CHPT) shares surged over 70% after its Q2 earnings beat expectations, with revenue of $116.1M and near-zero cash burn. The company reported record gross margins and reduced net losses, citing growth in subscription software and partnerships. Despite a broader decline in U.S. EV sales, ChargePoint's performance impressed investors. Analysts remain cautious, with a Hold rating and an average price target of $7.5.

$NVDAMedAI 8/10

Nvidia Is Near Its High While Its Biggest Chip Peers Sit 18% to 32% Below Theirs. These Are the Chip Stocks to Buy.

Nvidia (NVDA) is near its 52-week high, while peers AMD (AMD), Micron (MU), Broadcom (AVGO), and Marvell (MRVL) trade 18% to 32% below theirs. Nvidia reported $96.2B revenue in Q2 2027, up 106% YoY, with data center revenue at $89B. Broadcom and Marvell raised outlooks, with Broadcom targeting $230B AI revenue by 2028. AMD and Micron also showed strong growth but trade at higher multiples.